104 related articles for article (PubMed ID: 9227343)
1. Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas.
Ramires M; David L; Leitão D; Seixas M; Sansonetty F; Sobrinho-Simões M
J Pathol; 1997 May; 182(1):62-7. PubMed ID: 9227343
[TBL] [Abstract][Full Text] [Related]
2. Extent of spontaneous apoptosis in gastric cancer: relation to proliferative index, p53 expression, CD 34 expression and histopathological features.
Jesionek-Kupnicka D; Tenderenda M; Rutkowski P
J Exp Clin Cancer Res; 2002 Sep; 21(3):371-5. PubMed ID: 12385580
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
4. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of DNA topoisomerase II in human gastric disorders.
Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A
Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis.
Hoshi T; Sasano H; Kato K; Yabuki N; Ohara S; Konno R; Asaki S; Toyota T; Tateno H; Nagura H
Anticancer Res; 1998; 18(6A):4347-53. PubMed ID: 9891491
[TBL] [Abstract][Full Text] [Related]
7. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
8. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
9. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
10. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
[TBL] [Abstract][Full Text] [Related]
11. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
Walts AE; Lechago J; Bose S
Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
[TBL] [Abstract][Full Text] [Related]
12. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of the probability of skin metastasis in gastric cancer.
Inadomi T; Tan M; Suzuki H; Shigematsu C
Eur J Dermatol; 1999; 9(3):214-7. PubMed ID: 10210788
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
15. Correlation between iododeoxyuridine and MIB-1 labelling index in gastric carcinoma and adjacent normal gastric tissue.
Schipper DL; Wagenmans MJ; Peters WH; Wobbes T; Wagener DJ
Anticancer Res; 2000; 20(2A):707-14. PubMed ID: 10810344
[TBL] [Abstract][Full Text] [Related]
16. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
17. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
18. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
[TBL] [Abstract][Full Text] [Related]
20. [Malignancy in gastric cancer, with special reference to the distribution of BrdU-labelled cells].
Kamata T; Yonemura Y; Oyama S; Sugiyama K; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):335-9. PubMed ID: 2359389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
